| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.9M | +1511.8% |
| R&D Expense | $28.1M | -2.3% |
| SG&A Expense | $101.7M | +65.2% |
| Interest Expense | $31.8M | +70.1% |
| Pre-tax Income | -$457.1M | +12.9% |
| Income Tax | $3.9M | +193.5% |
| Net Income | -$341.9M | -13.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.34B | +313.4% |
| Short-term Investments | $2.00B | +291.8% |
| Accounts Receivable | $37.7M | +2594.7% |
| Inventory | $12.0M | +1030.6% |
| Current Assets | $2.46B | +309.6% |
| Total Assets | $5.01B | +425.3% |
| Current Liabilities | $150.3M | +98.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.5M | +43.3% |
| Capital Expenditures | $1.06B | +511.5% |
| Investing Cash Flow | -$1.54B | -785.1% |
| Financing Cash Flow | $3.83B | +390.7% |
| Free Cash Flow | -$1.14B | -278.4% |
| Long-term Debt |
| $2.21B |
| +1319.0% |
| Total Liabilities | $2.62B | +818.7% |
| Stockholders' Equity | $2.39B | +257.5% |